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Abstract: Alzheimer's disease (AD) is a disorder which is irreversible of 
the brain related to memory loss, mostly found in the old and aged 
population. Alzheimer's dementia results from the degeneration or loss of 
brain cells. The brain-imaging technologies most often used to diagnose AD 
is Magnetic resonance imaging (MRI). MRI or structural magnetic 
resonance is a very popular and actual technique used to diagnose AD. An 
MRI uses magnets and powerful radio waves to create a complete view of 
your brain. To actually detect the presence of Alzheimer’s, the MRI should 
me studied carefullyImplementation of CBIR Content Based Image Retrival 
which is a revolutionary computer aided diagnosis technique will create 
new abilities in MRI Magnetic resonance imaging in related image retrieval 
and training for recognition of development of AD in early stages. 
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Alzheimer’s disease is a common cause of a degenerative brain disease, dementia which is 
characterized by a decline in memory, language, problem solving and other cognitive skills. 
Alzheimer’s disease affects a person’s ability to perform everyday activities [1, 2, 3, 4]. It is a 
neurodegenerative disease, characterized by progressive impairment of neurons and synaptic 
functioning affecting more than 47 million of people worldwide [5, 6, 7].  
Alzheimer’s disease was first identified more than 100 years ago, but after almost 70 years, it was 
recognized as “major killer”, the most common cause of dementia. In the year 2006, 26600 thousand 
people suffered from this disease worldwide. Alzheimer’s disease is predicted to globally affect 1 in 
85 people [8] that is an estimate of 115400 thousand people will suffer from AD in 2050, and at least 
43% of prevalent cases need high level of care which can result in overwhelming consequences in 
terms of healthcare expenses and quality of life of patients and caregivers. Increasing life expectancy 
in devel oped countries has led to growth in number of cases of people affected by age-related 
neurodegenerative diseases, such as Alzheimer’s disease (AD) [9].  
Researchers have revealed ample information about Alzheimer’s, yet exact biologic changes that 
cause Alzheimer’s, reason for quick progress in a few compared to others and how the disease can be 
prevented, decelerated or stopped, is about to be discovered. AD affects people over 65 years of age, 
while early-onset Alzheimer’s disease is diagnosed before 65 years [10]. Even though some medical 
treatment may temporarily show encouraging effects, nothing has demonstrated the capability of 
preventing deterioration. People with mild cognitive impairment (MCI) are at the transitional stage 
from normal control (NC) to AD, and they might have a very high risk of deteriorating to dementia 
especially the AD type [11]. 
The current stage in the development of a product of clinical diagnosis of AD requires a specialty 
clinic and includes a medical examination, neuropsychological testing, neuroimaging, cerebrospinal 
fluid (CSF) analysis and blood examination. The above process is neither cost nor time-effective. 
Furthermore, given the rapidly aging worldwide population with a predictable dramatic increase of 
AD cases, there are inadequate numbers of specialty clinics and hospitals to meet the budding needs 
[12]. Plentiful effort has been expended in this direction, resulting in a variety of methods or 
approaches for early Alzheimer’s disease detection with MRI data. Those approaches address the 
extraction of discriminative features, the selection of the most apt features from a large pool of 
features, and the selection of efficient classification models from machine learning and computational 
intelligenc [13]. 
 
2. Survey Study 
Yao, D, et al [2] proposes a process by converting the 4-way classification into five binary 
classification problems which is a hierarchical process. A feature selection technology which is new 
was also proposed which identifies more informative and brief subset from 3 demographic features 
and 426 s MRI morphometric, to ensure that highest accuracy is achieved by each binary classifier.  
The method gives a new framework using hierarchical grouping for multi way classification and 
accurate feature selection. 
While Jin Liu, et al [3] uses MRI images to detect the Alzheimer’s disease and also developing 
stage where MCI (Mild Cognitive Impairment) gets converted to Alzheimer’s disease. The whole 
brain is of four sections named as 90, 54, 14 and 1 regions divided based on AAL (Automated 
Anatomical Labelling). For data pre-processing Pearson correlation is taken and for the feature 
selection F-scores was used to lessen the dimensionality of features. In final stage, MKBoost 
(Multiple Kernel Boosting) algorithm for classification of the disease from the healthy control (HCs). 
Amoroso, N, et al [4] used Random Forest feature selection and Deep Neural Network 
classification  and presented a classification strategy using a mixed unit including the four classes of 
classification problem, I,e HC, AD, MCI, cMCI, for training the model. Also, they compared this 
method with an original classification strategy based on fuzzy logic learned on a mixed unit including 
only Healthy Control and Alzheimer’s disease. Actually, they intend to examine if DNN accuracy can 
be better after 344 combining different imaging modalities or by adding non-MRI images. 
Lie, et al [5] was the first on the basis of the availability of different modalities divide the actual 
data into multiple views and then they build a hypergraph in each view space on the basis of sparse 
representation. VAHC (View Aligned Hypergraph Classification) model is then given, based on view-
aligned regularize to capture consistency among all the views. They then collect the class probability 
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scores produced from VAHC, by using a multi-view label fusion method used for making a final 
classification decision. They assessed their method on the baseline ADNI-1 database with 807 themes 
and three modalities which are MRI, PET, and CSF. The results prove that their method beats state-
of-the-art approach that use unfinished multi-modality data for AD/MCI diagnosis. 
Jun Zhang, et al 6] uses Magnetic Resonance Images (MRI) images for the early detection of AD 
using AD landmarks for distinguishing AD subjects from Healthy control in the first phase nonlinear 
registration subjects and the second step with the brain tissue segmentation. For pre-processing the 
data voxel wise comparisons is done on the datasets. For feature selection they have used random 
forest. The morphological features were extracted from the AD landmarks which was identified for 







Figure 1.     Diagram Illustrating the Steps in 
the Proposed Landmark Detection and AD Classification Framework 
 
 
In general, the proposed framework defines three sequential steps: 
1. Landmark definition 
2. Landmark Detection 
3. AD/HC Classification 
 
 
Loris Nanni, et al [7] gave a technique to perform early diagnosis of AD, on both MRI images and 
blood plasma proteins expression values, combining different feature reduction approaches. SVM 
(Support vector machine) is trained by Every selected set of features, then the weighted sum rule is 
used to combined set of SVMs. SVM is basically trained with the feature vector of proposed images 
where the images and used to train an SVM are quarried from the image. 
K.R. Kruthikaa, et al [14] uses all the MRI images to detect the Alzheimer’s disease using the 
Content based image retrieval (CBIR) techniques. The data-pre-processing of data is done using the 
software known as statistical parametric (SPM) version 1.2 and for learning and training process 
sparse autoencoder. The final stage for classification capsule network is used for differentiating 
Alzheimer’s from healthy control. 
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Ronghui Ju, et al [15] used deep learning with brain network and few other related information to 
make early analysis of AD. The other related information include gender, age and ApoE gene of the 
subject. Computing the functional connectivity of brain regions using R-fMRI (Resting - State 
Functional Magnetic Resonance Imaging) data, facilitates construction of the brain network. Aging 
and MCI, an early stage of AD, is distinguished by building a targeted autoencoder network chwhi 
provides a dependable classifier for Alzheimer’s detection. 
Lulu Yue, et all [16] employed DCNN depp convolutional neural network to obtain the most 
suitable features from the MRI images of patients. The MRI images are pre-processed in a stern 
pipeline manner at first. Then, each volume is re-sliced, and put the same into a DCNN directly. At 
last 4 different stages of AD are known. 
 
3. Methodology 
Yao et all [2] used a 4 different classification for predicting alzheimer’s disease and Mild Cognitive 
Impairment (MCI) happens in different ages of people. The 4-way classification is classified into 
AD, MCI, cMCI and healthy control. The machine learning approaches are imposed for pre-
processing the data which was taken from Kaggle hosted by a competition, on the T1-weighted 
MRI images data and information from the International Alzheimer’s Disease Neuroimaging 
(ADNI) database. There are some calculated scores for virtual data like MMSE which specifies that 
it may loose some useful information like p-Values on virtual data which do not exist momentous 
difference. For the feature selection, different traditional methods are compared with the algorithms 
like Forward selection and SVM-FRE which was gave number of features, accuracy, sensitivity and 
specificity. Forward selection is a type of regression which begins with an empty model and adds all 
variables one by one. In each forwarded step, it add one variable that gives the single best 
improvement to the model. Then for the binary classification SVM defined as supervise machine 
learning algorithm which can be used for classification or regression problems. It uses different 
technique called the KT (Kernel Trick) to transform data and then based on these transformations it 
finds an optimum boundary between the possible outputs.54.38% accuracy which was achieved 
with the 4-way classification on the testing data. 
Loris Nanni, et all [7] uses brain MRI studies for the early recognition of the Alzheimer’s 
disease. For the feature selection approaches like Fisher Scores (based on different methods), Gini 
Index (an arithmetical measure of dispersion), T-test (based on different student’s distribution), 
Sparse multinomial logical regression via Bayesian L1 regularization and so many. For the 
classification purpose convolutional neural network is used for reshaping the vector into a matrix 
methods which are used like Triplet, Continuous Wavelet, Random reshaping and Gabor filter 
feature extraction. Triplet is defined by highlighted vector that describes a pattern which is then 
regularized to a vector. Random reshaping is randomly sorting the original vector which can be fed 
to the SVM which is next used for the classification between different classification OD detection 
between AD vs MCI and others. The accuracy of 92.4% for AD and CN, 85.5% for MCIc and CN, 
67.5% for MCIc and MCInc and 96.8% for MRI after using Fisher method. 
Lulu Yue, et all [16] uses to analyse the Alzheimer’s with many symptoms such as weakening of 
memory and language on ages. Traditional methods of diagnosing AD and mild cognitive 
impairment non-parametric non uniform bias correction (N3 algorithm), both are done with grinder 
pipeline software. A machine learning pipeline are used to help automate machine 
learning workflows and algorithms. They operate by empowering a sequence of data to be 
transformed and associated together in a model that can be tested and assessed to achieve an 
outcome, whether it is positive or negative. Then brain extraction is used with FSL-BET toolbox, 
FSL is an inclusive library of analysis tools for FMRI, MRI and DTI brain imaging data. Most of 
the tools can be track both from the command line and as GUIs (Graphical User Interfaces). The 
features extracted with the grey matter (gm), White Matter (wm).The method for the classification 
such as SVM which gave accuracy of 81.04% for NC vs AD, 76.98% for NC vs MCI and 70.15% 
for AD vs MCI. Convolutional Neural Network (CNN) results with the accuracy of 95.441% for 
NC and AD, 95.38% for NC and MCI and 93.88% AD and MCI. 
Jin Liu, et all [3] uses different region of interest for analysis of brain magnetic resonance 
imaging to predict the disease and also the initial developing stage where mild congnitive 
impairment (MCI) transformed into AD. The whole brain parts are divided into 4 sections names as 
90, 54, 14 and 1 zones differentiated based on the automated anatomical labelling. For data pre- 
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processing Pearson correlation is taken after which for the feature selection F-scores was used to 
reduce the dimensions of features and for the feature ranking. So, the greater the F-scores, area 
more likely that the feature will be discriminative. The final stage is multiple kernel boosting 
algorithm for the classification. Multiple Kernel Boosting (MKboost) algorithm is a machine 
learning algorithm which has attracted many attentions in recent years and for the SVM toolbox, 
LBSVM are used. It is an open source machine learning library written in c++ and used c API. The 
classification results with accuracy of 94.65%. 
Kruthikaa & Maheshappa [14] uses all the MRI images to predict the Alzheimer’s disease using 
the Content Based Image Retrieval (CBIR) techniques. The data pre-processing are done with the 
software known as statistical parametric (SPM) version 1.2. For learning and training purpose 
sparse autoencoder had been used. The final stage of classification, capsule networks are used for 
differentiating alzheimer’s from healthy control. Skull scraping and normalizing had ensure the 
compatibility between images after transforming original brain images into standard image space. 
Using autoencoder which is a 3-layered artificial neural network, basically used for the 
unsupervised data to differentiate between different kinds of data. 
 
4. Result Comparison 
 




Tabel 1.     Comparison the Result of the Papers [7, 4, 16] 
 
PAPER METHODS AND ACCURACY 
[7] 
METHOD ADvs CN MCIc vs CN MCIc vsMCInc MRI 
Gini 85.6 80.5 63.2 82.4 
Fi 92.4 85.5 67.5 96.8 
SBMLR 91.5 83.3 68 94.7 
Ttest 91 82.2 64.2 95.2 
[14] 
METHOD MCI vs AD NC vs AD NC vs MCI   
CAPSULE NETWORK 94.6 92.8 94.04   
[16] 
METHODS NCvs AD NC vs MCI AD vs MCI   
CNN 95.441 95.388 93.888   
SVM 81.04 76.98 70.15   






From all the above papers we have discussed in the above sections we have come to the conclusion 
that only 4 papers are more relevant to our project. We are going to use the MRI(magnetic Resonance 
Images) as a data set, to detect the Alzheimer’s disease and also developing stage where Mild 
Cognitive Impairment (MCI) gets converted to AD from the Classification of Alzheimer’s disease 
using whole brain hierarchical network paper, MKBoost (Multiple Kernel Boost) algorithm for 
classification of the disease from the Healthy Control (HCs) and from the paper 3 they use all the 
MRI images to detect the AD using the Content Based Image Retrieval (CBIR) techniques. We have 
come to the conclusion that from paper1 CNN method can be used as it has the highest accuracy than 
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the other algorithms used in the paper. Paper has the most accuracy for SBMLR method therefore it 
can be used in the paper. 
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